Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome

British Journal of Dermatology

Volumn 155, Issue 2, 2006, Pages 344-349

  Seishima, M ^a   Yamanaka, S ^a   Fujisawa, T ^a   Tohyama, M ^b   Hashimoto, K ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytomegalovirus; Drug eruption; Drug induced hypersensitivity syndrome; Epstein Barr virus; Human herpesvirus 6; Human herpesvirus 7

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PHENOBARBITAL; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA; ZONISAMIDE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DETERMINATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; ERYTHEMA; FEMALE; FEVER; HERPES SIMPLEX VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOFLUORESCENCE TEST; LYMPHADENOPATHY; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MALE; PATCH TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS REACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; DNA, VIRAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; MALE; MIDDLE AGED; VIRUS ACTIVATION;

EID: 33745906565     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07332.x     Document Type: Article

References (20)

1. Suzuki Y, Inagi R, Aono T et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-12.
2. Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113-17.
3. Descamps V, Mahe E, Houhou N et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003; 148: 1032-4.
4. Aihara M, Sugita Y, Takehashi S et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001; 144: 1231-4.
5. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140: 183-8.
6. Hashizume H, Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol (Stockh) 2005; 85: 47-50.
7. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003; 3: 255-60.
8. Aihara Y, Ito S-I, Kobayashi Y et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149: 165-9.
9. Shiohara T, Kano Y. Are viral infections responsible for the development of drug-induced hypersensitivity syndrome as well as graft-versus-host diseases? Dermatology 2005; 210: 259-60.
10. Kano Y, Shiohara T. Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm Venereol (Stockh) 2004; 84: 484-5.
11. Mitani N, Aihara M, Yamakawa Y et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005; 75: 430-4.
12. Arakawa M, Kakuto Y, Ichikawa K et al. Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia. Intern Med 2001; 40: 331-5.
13. Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J Dermatol 2005; 32: 278-81.
14. Hara H, Kobayashi M, Yokoyama A et al. Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 2005; 211: 159-61.
15. Maeda Y, Teshima T, Shinagawa K et al. Monitoring of human herpesvirus after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Br J Haematol 1999; 105: 295-302.
16. Kano Y, Inaoka M, Sakuma K et al. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005; 209: 165-7.
17. Flamand L, Stefanescu I, Ablashi DV et al. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993; 67: 6768-77.
18. Lalani AS, Barrett JW, McFadden G. Modulating chemokines: more lessons from viruses. Immunol Today 2000; 21: 100-6.
19. Katsafanas GC, Schirmae EC, Wyatt LD et al. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA 1996; 94: 9788-92.
20. Le Cleach L, Fillet AM, Agut H et al. Human herpesviruses 6 and 7: new roles yet to be discovered. Arch Dermatol 1988; 134: 1155-7.